On October 18, 2023 Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, reported that it will be presenting at the following upcoming scientific conferences (Press release, Inhibrx, OCT 18, 2023, View Source [SID1234636121]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Connective Tissue Oncology Society (CTOS) 2023 Annual Meeting
November 1st – 4th, 2023 – Dublin, Ireland
Title: The Tetravalent Death Receptor 5 Agonist INBRX-109 Combined With Chemotherapy in Ewing Sarcoma: Preliminary Data From A Phase 1 Study
Lead Author: Rashmi Chugh, MD
Poster presentation on Thursday, November 2nd, 2023 from 5:30 PM – 6:30 PM Irish Standard Time
Location: The Liffey Convention Centre in Dublin, Ireland
Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) 38th Annual Meeting
November 3rd – 5th, 2023 – San Diego, California
Title: Phase 1/2 Study of the Bispecific 4-1BB and PD-L1 Antibody INBRX-105 Alone and in Combination With Pembrolizumab in Select Solid Tumors
Lead Author: Jong Chul Park, MD
Abstract: 742
Trial-in-progress poster presentation on Saturday, November 4th, 2023 from 9 AM – 8:30 PM Pacific Standard Time
Location: San Diego Convention Center, San Diego, CA – Hall A
Presentation Title: Phase 1/2 Study of the Hexavalent OX40 Agonist INBRX-106 Alone and in Combination With Pembrolizumab in Select Solid Tumors
Lead Author: Rachel E. Sanborn, MD
Abstract: 748
Trial-in-progress poster presentation on Saturday, November 4th, 2023 from 9 AM – 8:30 PM Pacific Standard Time
Location: San Diego Convention Center in San Diego, CA – Hall A
The posters will be accessible through a link on the investors’ section of Inhibrx’s website at View Source upon commencement of each respective presentation.